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The total number of OPIOID OVERDOSE 
deaths in the Commonwealth has 
INCREASED FIVE-FOLD in the last 20 years 
Substance Use-Related Death:  
199 pregnancy-associated deaths 
identified in MA from 2005-2014
Approximately 1 in 5 (20.6%, n=41) 
was related to substance use
Increasing Trend of Substance Use-Related Deaths
Pregnancy-associated death in which  ACUTE or CHRONIC substance use 
contributed directly to the death as indicated on the death certificateNot limited to opioid use or overdose deaths 
A majority (90.2%) of the substance use-related deaths occurred in the 
postpartum period, between 42-<365 days postpartum
Types of Substances Identified 
Among Pregnancy-Associated Deaths
Drug Category % Substance Use-Related Deaths (N=41)
Opioids 65.9%
Cocaine 17.1%
Methamphetamine (methylphenidate, ritalinic acid) 2.4%
Benzodiazepines (benzodiazepine, alprazolam, 
clonazepam) 12.2%
Alcohol (ethanol) 4.9%
General/Unspecified (chronic substance abuse, 
polysubstance abuse, drug overdose) 24.4%
Substance Use Among Pregnancy-Associated Deaths 
Massachusetts 2005-2014 
Addressing Substance 
Use Before, During, 
and After Pregnancy:
MDPH recommends screening all pregnant women 
through interviews using a standard tool at:
          The beginning of pregnancy
          28 weeks
          Time the women presents for delivery
Coordination between SUD treatment and obstetric providers following 
delivery is crucial as well as warm handoffs to on-going treatment such as:
          Early Intervention
          Home visting
          Substance use and mental health treatment providers
          Parenting classes
          
The content of this infographic is discussed in the 
“Substance Use among Pregnancy-Associated 
Deaths- Massachusetts, 2005-2014” brief on the 
Massachusetts Department of Public Health website.  
The Massachusetts Perinatal Quality Collaborative (MPQC) 
has published an online toolkit to support maternal health 
clinicians in using best practices to prevent, identify, and 
treat substance use disorders among pregnant women.
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